Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Print this page Email this page Users Online: 373
CASE REPORT
Year : 2021  |  Volume : 14  |  Issue : 2  |  Page : 230-233

Dual antiplatelet therapy challenges in emergent noncardiac surgeries


Department of Anesthesiology and Critical Care, Maulana Azad Medical College, University of Delhi, New Delhi, India

Correspondence Address:
Anisha Singh
Department of Anesthesiology and Critical Care, Maulana Azad Medical College, University of Delhi, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mjdrdypu.mjdrdypu_252_20

Rights and Permissions

In today's era, patients with coronary stents are presenting for various surgeries while still being on dual antiplatelet therapy. This leads to balancing the risk between myocardial ischemia if therapy is discontinued and bleeding risk due to surgery. Hence, it arises the need to introduce guidelines for managing such patients coming for elective as well as emergency surgeries for easy implementation. Developments related to coronary stents and antiplatelet agents are continuously evolving. A comprehensive understanding of the pharmacology of newer antiplatelet agents, efficacies of newer coronary stents, risk of stent thrombosis, and role of platelet function tests must be determined. There is an urgent need for the development of guidelines to manage such patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed92    
    Printed0    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal